期刊名称：ACTA BIOCHIMICA ET BIOPHYSICA SINICA
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
Acta Biochimica et Biophysica Sinica (ABBS) is an internationally peer-reviewed journal sponsored by the Institute of Biochemistry and Cell Biology (SIBS, CAS). ABBS aims to publish original research articles and review articles in diverse fields of biochemical research including Protein Science, Nucleic Acids, Molecular Biology, Cell Biology, Biophysics, Immunology, and Signal Transduction, etc.
ABBS was launched in 1958 by Shanghai Institute of Biochemistry (CAS) and has established itself over the past five decades as one of the most influential biochemical journals in China. It is highly appreciated by scientists throughout the country. Since 2004, ABBS has turned into a full English journal published monthly. From 2005 to 2008, ABBS launched its online version.
ABBS is covered by the following major indexing services:
Abstracts on Hygiene and Communicable Diseases
Agbiotech News and Information
Agroforestry Abstracts
Biocontrol News and Information
CAB Abstracts
Calcium and Calcified Tissue Abstracts
Chemical Abstracts
Crop Physiology Abstracts
Dairy Science Abstracts
Field Crop Abstracts
Forest Products Abstracts
Forestry Abstracts
Global Health
Grasslands & Forage Abstracts
Helminthology Abstracts
Horticultural Abstracts
IndexCopernicus
Index Veterinarius
Pig News & Information
Plant Breeding Abstracts
Plant Growth Regulators
Potato Abstracts
Poultry Abstracts
Protozoological Abstracts
Scopus
Sugar Industry Abstracts
Tropical Diseases Bulletin
Veterinary Bulletin
Weed Abstracts
Wheat, Barley and Triticale Abstracts
Instructions to Authors
SCOPE OF JOURNAL
Acta Biochimica et Biophysica Sinica is a scientific journal publishing monthly research papers, rapid communications and reviews in biochemistry, molecular biology and biophysics. Research papers and rapid communications should report original work not published or considered for publication elsewhere. Reviews should provide a concise introduction to the subject matter to inform the readers of the latest developments in a certain area.
EDITORIAL REVIEW AND ACCEPTANCE
The acceptance criteria for a manuscript are the quality and originality of the research and its significance to our readership. Except where otherwise stated, manuscripts are single-blind peer reviewed by at least two anonymous reviewers and the editor. Final acceptance or rejection rests with the Editorial Board, who reserves the right to refuse any material for publication.
SUBMISSION OF MANUSCRIPTS
Manuscripts should be written in English and must be submitted online through our ScholarOne Manuscripts System. For full ScholarOne Manuscripts Instructions click here. Once you have prepared your manuscript according to the instructions please visit the online submission website.
Initial submission should include a cover letter (filling in the cover letter section) stating that: (i) the content has not been published or submitted for publication elsewhere; (ii) all authors have contributed significantly and are in agreement with the content of the manuscript. Authors must declare any financial support or relationships that may pose conflict of interest. If tables or figures have been reproduced from other sources, a letter from the copyright holder (usually the Publisher) stating authorization to reproduce the material must be attached to the covering letter.
Submission of revised manuscript should include: (i) the revised manuscript with revisions marked, (ii) a letter answering all reviewers’ questions point by point.
Submission of the final manuscript should include: (i) the revised manuscript with revisions marked. (ii) an agreement on transferring the copyright to the Institute of Biochemistry and Cell Biology with corresponding author's signature.
If you have difficulties in using the online submission system, please feel free to contact the Editorial Office at the following address:
Editorial Office of Acta Biochimica et Biophysica Sinica
The Institute of Biochemistry and Cell Biology, SIBS, CAS
320 Yueyang Road, Shanghai 200031, China
Tel: 86-21-54920956/54920955/52920954/54922862
Fax: 86-21-54921091
E-mail: abbs@sibs.ac.cn
COPYRIGHT
New for 2010 – Please note that the journal now encourages authors to complete their copyright licence to publish form online
Copyright of any article published in ABBS will belong to the author or their designee. However, it is a condition of publication in the journal that authors grant an exclusive licence to publish to Oxford University Press. This ensures that requests from third parties to reproduce articles are handled efficiently and consistently and allows the article to be as widely disseminated as possible. As part of the licence agreement, authors may use their own material in other publications provided that the Journal is acknowledged as the original place of publication and Oxford University Press as the Publisher. Manuscripts will not be published without submission of an original signed copyright form.
Authors are reminded that it is their responsibility to comply with copyright laws. It is essential to ensure that no part of the text or illustrations have appeared or are due to appear in other publications, without prior permission from the copyright holder. Signed patient consent forms must be obtained for recognizable photographs. Submission of the manuscript will be taken to indicate the authors compliance with these conditions.
Upon receipt of accepted manuscripts at Oxford Journals authors will be invited to complete an online copyright licence to publish form.
Please note that by submitting an article for publication you confirm that you are the corresponding/submitting author and that Oxford University Press ("OUP") may retain your email address for the purpose of communicating with you about the article. You agree to notify OUP immediately if your details change. If your article is accepted for publication OUP will contact you using the email address you have used in the registration process. Please note that OUP does not retain copies of rejected articles.
The corresponding author will be asked to complete the online licence to publish form upon acceptance of their manuscript. No article will be published unless the licence has been received at Oxford Journals.
As the Author(s), copyright of the Article remains yours (or your employer’s if your employer claims copyright in your work). See here for full details of Oxford Journals' copyright policy.
OPEN ACCESS
Authors have the option, at an additional charge, to make their paper freely available online immediately upon publication, under the Oxford Open initiative. After your manuscript is accepted, as part of the mandatory licence required of all corresponding authors, you will be asked to indicate whether or not you wish to pay to have your paper made freely available immediately. If you do not select the Open Access option, your paper will be published with standard subscription-based access and you will not be charged.
For those selecting the Open Access option, the charges vary depending on the institution at which the Corresponding author is based:
New charges for ALL Open Access papers accepted on or after 1 December 2009
For an author based at an institution with a full price online subscription:
Regular charge - £1275 / $2250 / €1900
List B developing country charge** - £638 / $1125 / €950
List A developing country charge** - £0 / $0 / €0
For an author based at an institution that does not have a full price online subscription:
Regular charge - £1700 / $3000 / €2550
List B developing country charge** - £850 / $1500 / €1275
List A developing country charge** - £0 /$0 / €0
Orders from UK will be subject to a 17.5% VAT charge. For orders from the rest of the EU, we will assume that the service is provided for business purposes, please provide a VAT number for yourself or your institution and ensure you account for your own local VAT correctly.
The above Open Access charges are in addition to any page charges and colour charges that might apply.
If you choose the Open Access option you will also be asked to complete an Open Access charge form online . You will be automatically directed to the appropriate version of the form depending on whether you are based at an institution with an online subscription. Therefore please make sure that you are using an institutional computer when accessing the form. To check whether you are based at a subscribing institution please use the Subscriber Test link for ABBS.
ABBREVIATIONS
Abbreviations should be used sparingly: only where they ease the reader's task by reducing repetition of long, technical terms. Initially use the word in full, followed by the abbreviation in parentheses. Thereafter use the abbreviation only.
Genetic nomenclature Standard genetic nomenclature should be used. For further information, including relevant websites, authors should refer to the genetic nomenclature guide in Trends in Genetics (Elsevier Science, 1998).
Nucleotide sequence data can be submitted in electronic form to any of the three major collaborative databases: DDBJ, EMBL or GenBank. It is only necessary to submit to one database as data are exchanged between DDBJ, EMBL and GenBank on a daily basis. The suggested wording for referring to accession-number information is: 'These sequence data have been submitted to the DDBJ/EMBL/GenBank databases under accession number U12345.' Addresses are as follows:
DNA Data Bank of Japan (DDBJ) http://www.ddbj.nig.ac.jp
EMBL Nucleotide Sequence Submissions http://www.ebi.ac.uk
GenBank http://www.ncbi.nlm.nih.gov
FORMAT OF MANUSCRIPT
An example of the correct format for submitted papers is available on our website. Research papers should be arranged in the following order: (i) title, author(s) and affiliation(s); (ii) running title; (iii) abstract and keywords; (iv) introduction; (v) materials and methods; (vi) results; (vii) discussion; (viii) references; (ix) footnote; (x) figure legends; (xi) tables; (xii) figures. Rapid communications should be arranged in the following order: (i) title, author(s) and affiliation (s); (ii) running title; (iii) abstract and keywords; (iv) introduction; (v) experimental procedures; (vi) results and discussion; (vii) references; (viii) footnote; (ix) figure legends; (x) tables; (xi) figures. The locations of figures and tables in the text should be indicated. Footnotes to the text are not allowed and any such material should be incorporated into the text as parenthetical matter.
Title: The title should be short and informative, less than 20 words, and should not include non-standard acronyms or abbreviations.
Title page: The title page should contain (i) the title of the paper, (ii) the full names of the authors and (iii) the addresses of the institutions at which the work was carried out together with (iv) the full postal and email address, plus facsimile and telephone numbers, of the author to whom correspondence about the manuscript should be sent. The present address of any author, if different from that where the work was carried out, should be supplied in a footnote.
Running title: A running title should be provided and should be less than 60 characters.
Abstract: The abstract should describe clearly the aim, major findings and conclusions of the research. It must not exceed 250 words.
Keywords: Five or fewer key words should be listed below the abstract. Keywords should be taken from those recommended by the Index Medicus Medical Subject Headings (MeSH) browser list at http://www.nlm.nih.gov/mesh/meshhome.html
Introduction: The basic principles of research, background, earlier related work and the purpose of the present studies should be described in the introduction.
Experimental procedures: Experimental procedures should be brief but complete enough to be repeated; procedures published previously should be cited in references.
Results: It is recommended that results be presented in figures and tables along with a suitable description in the text.
Discussion: The discussion should be concise (no more than three pages) and focus on the interpretation of the results.
References: The Vancouver system of referencing should be used (examples are given below). In the text, references should be marked using [Arabic numerals] in the order in which they appear.
In the reference list, if a reference has many authors, list only the first seven authors, followed by 'et al.' Reference to unpublished data and personal communications should not appear in the list but should be cited in the text only (e.g. Smith A, 2000, unpublished data). All citations mentioned in the text, tables or figures must be listed in the reference list.
Names of journals should be abbreviated according to the style used in Index Medicus. Authors are responsible for the accuracy of the references.
1 Neufeld EB, Remaley AT, Demosky SJ, Stonik JA, Cooney AM, Comly M, Dwyer NK et al. Cellular localization and trafficking of the human ABCA1 transporter. J Biol Chem 2001, 276: 27584-7590.
2 Hanahan D, Jessee J, Bloom FR. Techniques for transformation of E. coli. In: Glover DM, Hames BD eds. DNA Cloning: A Practical Approach. 2nd ed. England: Oxford University Press 1998, 122-123.
Footnotes: A footnote below the key words can include (1) source of grants, (2) present address of any author(s) if required, and (3) abbreviations used in the text.
Tables: Tables should be self-contained and complement, but not duplicate, information contained in the text. Tables should be consecutively numbered in the text in Arabic numerals. Legends should be concise but comprehensive: the table, legend and footnotes must be understandable without reference to the text. Vertical grid lines should not be used to separate columns. Each column in a table must have a heading, with units of measurement in parentheses; all abbreviations must be defined in footnotes.
FIGURES
Please be aware that the requirements for online submission and for reproduction in the journal are different: (i) for online submission and peer review, please upload your figures either embedded in the word processing file or separately as low-resolution images (.jpg, .tif, .gif or. eps); (ii) for reproduction in the journal, you will be required after acceptance to supply high-resolution .tif files (1200 d.p.i. for line drawings and 300 d.p.i. for colour and half-tone artwork) or high-quality printouts on glossy paper. We advise that you create your high-resolution images first as these can be easily converted into low-resolution images for online submission.
For useful information on preparing your figures for publication, go to http://cpc.cadmus.com/da/index.jsp. Figures will not be relettered by the publisher. The journal reserves the right to reduce the size of illustrative material. Any photomicrographs, electron micrographs or radiographs must be of high quality. Wherever possible, photographs should fit within the print area of 169 x 235 mm (full page) or within the column width of 82 mm. Photomicrographs should provide details of staining technique and a scale bar. Patients shown in photographs should have their identity concealed or should have given their written consent to publication. Normally no more than six illustrations will be accepted for publication in the print issue without charge.
Figures should be cited in consecutive order in the text, if possible. Graphs should be drawn professionally or with a computer graphics package. Pictures should be supplied electronically. Individual photographs forming a composite figure should be of equal contrast. Magnifications should be indicated using a scale bar on the illustration.
Figure legends should be concise but comprehensive: the figure and its legend must be understandable without reference to the text. Include definitions of any symbols used and define/explain all abbreviations and units of measurement.
The quality of reproduction is limited by the quality of the submitted material. All figures must be of high quality - they should be sharply focused, have good contrast and any lettering must be clear and legible. Colour illustrations can be reproduced if there is sufficient scientific merit in doing so. Authors will be expected to bear the cost of colour origination by the Journal’s printers.
Guidance for preparation of Figures
Figures should be sized to fit a single column of the Journal where possible (88 mm) or a double column if necessary (180 mm). The preferred font for lettering is Times; lettering should have an upper case height of 2 mm and a lower case height of 1 mm at publication size (corresponding to point size 8). Line thickness should be set at 0.5 points. Shading used on line drawings should be clear and distinctive; shades of grey and heavy stippling do not reproduce well. Lines and symbols should be drawn boldly enough to withstand reduction. The preferred symbols are filled circles, open circles, filled squares, open squares, filled triangles and open triangles, and should be no smaller than 1 mm (height/diameter) at publication size. Part labels should be lower case letters within parentheses, e.g. (a), (b), (c) etc.
FUNDING
The following rules should be followed:
The sentence should begin: ‘This work was supported by …’
The full official funding agency name should be given, i.e. ‘the National Cancer Institute at the National Institutes of Health’ or simply 'National Institutes of Health' not ‘NCI' (one of the 27 subinstitutions) or 'NCI at NIH’ - see the full RIN-approved list of UK funding agencies for details
Grant numbers should be complete and accurate and provided in brackets as follows: ‘[grant number ABX CDXXXXXX]’
Multiple grant numbers should be separated by a comma as follows: ‘[grant numbers ABX CDXXXXXX, EFX GHXXXXXX]’
Agencies should be separated by a semi-colon (plus ‘and’ before the last funding agency)
Where individuals need to be specified for certain sources of funding the following text should be added after the relevant agency or grant number 'to [author initials]'.
An example is given here: ‘This work was supported by the National Institutes of Health [P50 CA098252 and CA118790 to R.B.S.R.]
and the Alcohol & Education Research Council [HFY GR667789].
Oxford Journals will deposit all NIH-funded articles in PubMed Central. See Depositing articles in repositories – information for authors for details. Authors must ensure that manuscripts are clearly indicated as NIH-funded using the guidelines above.
CONFLICT OF INTEREST
Conflicts of interest have the potential to affect authors, referees and Editors. ABBS has the following systems in place to deal with conflicts of interest:
Authors. Authors are required to include a Transparency declarations section in every submission to the Journal (for details see below).
Referees. When invited to act, and again when they agree to act, referees are reminded to consider whether they have any potential conflicts of interest. Referees are asked to discuss any perceived potential conflict with the Editor of the article who will reach a decision as to whether it is appropriate that the referee acts on the article or whether they should withdraw.
Editors. The Editor-in-Chief and Editors register their interests (including personal and business interests) with the Society. When an article is assigned to an Editor the Editor is reminded to consider whether there are any potential conflicts of interest, and if so, to discuss them with the Editor-in-Chief, who will come to a decision as to whether it is appropriate for the Editor to act on the article, or whether it should be reassigned.
PERMISSIONS
Authors must:
obtain permission from the original publisher and, if requested, the original author (i.e. the corresponding author of the article from which the figure/table has come) for reproducing/modifying figures/tables.
request the following when seeking to reproduce any kind of third party material:
(i) non-exclusive rights to reproduce the material in the specified article and journal.
(ii) print and electronic rights, preferably for use in any form or medium.
(iii) the right to use the material for the life of the work.
(iv) world-wide English-language rights. If rights for all languages can be secured, this is preferable.
(v) the right to use images with a resolution of 150 dpi in the PDF version of the journal or 72 dpi in the HTML version.
include a statement indicating that permission has been obtained in the relevant legend/footnote.
provide the Editorial Office with copies of any relevant paperwork.
For further details, as well as a template permissions request letter, please contact the Editorial Office.
SUPPLEMENTARY DATA
Only directly relevant experimental data should be included in the full text of manuscripts. Supporting data should be submitted for review as supplementary material, in a separate file from the manuscript, for publication online only. Material that has not been peer-reviewed will be made available only through a link to the author's home page, at the discretion of the Editor. Supplementary Material can be published in these formats: .txt, .htslp, .shtml, .html, .htm, .jpg, .jpeg, .gif, .mov, .mpg, .avi, .pdf, .xls, .zip, .doc, .rtf, .tif, .dtl.
PROOFS
Authors will receive a PDF file of the complete paper by email. In the interest of speed, corrections must be returned within 48 hours.
OFFPRINTS
The Journal will provide the authors with free online access to their article, with the option of purchasing printed offprints. Offprint order forms are sent out with PDF proofs and must be returned with the faxed corrections, or posted to ABBS, Oxford Journals, Oxford University Press, Great Clarendon Street, Oxford OX2 6DP, UK. Late orders submitted after the Journal has been printed are subject to increased prices.
Editorial Board
EMERITUS EDITOR-IN-CHIEF
Youshang ZHANG
EDITOR-IN-CHIEF
Boliang LI
DEPUTY EDITOR-IN-CHIEF
Minghua XU
EDITORS
Ta-Yuan CHANG (Dartmouth Medical School, Hanover)
Zengyi CHANG (Peking University, Beijing)
Chang-zheng CHEN (Stanford University, Stanford)
Jiangye CHEN (Institute of Biochemistry and Cell Biology, Shanghai)
Quan CHEN (Institute of Zoology, Beijing)
Xiao-dong CHENG (University of Texas Medical Branch, Galveston)
Jianping DING (Institute of Biochemistry and Cell Biology, Shanghai)
Yan FENG (Jilin University, Changchun)
Suzanne AW FUQUA (Baylor College of Medicine, Houston)
Jun-lin GUAN (University of Michigan Medical School, Ann Arbor)
Lin HE (Shanghai Jiaotong University, Shanghai)
Guo-fu HU (Harvard Medical School, Boston)
Hongyu HU (Institute of Biochemistry and Cell Biology, Shanghai)
Youxin JIN (Institute of Biochemistry and Cell Biology, Shanghai)
Naihe JING (Institute of Biochemistry and Cell Biology, Shanghai)
Lin LI (Institute of Biochemistry and Cell Biology, Shanghai)
Yanmei LI (Qinghua University, Beijing)
Songping LIANG (Hunan Normal University, Changsha)
Qishui LIN (Institute of Biochemistry and Cell Biology, Shanghai)
Changde LU (Institute of Biochemistry and Cell Biology, Shanghai)
Kangcheng RUAN (Institute of Biochemistry and Cell Biology, Shanghai)
Binghui SHEN (Beckman Research Institute)
Jianguo SONG (Institute of Biochemistry and Cell Biology, Shanghai)
Rui WANG (Lanzhou University, Lanzhou)
Enduo WANG (Institute of Biochemistry and Cell Biology, Shanghai)
Qiang WU (University of Utah Medical School, Salt Lake City)
Guoliang XU (Institute of Biochemistry and Cell Biology, Shanghai)
Libo YAO (Fourth Military Medical University, Xi'an)
Rong ZENG (Institute of Biochemistry and Cell Biology, Shanghai)
Xiliang ZHA (Fudan University Medical School, Shanghai)
Fukun ZHAO (Institute of Biochemistry and Cell Biology, Shanghai)
Dahai ZHU (Chinese Academy of Medical Sciences, Beijing)
EDITORIAL BOARD MEMBERS
Vasso APOSTOLOPOULOS (Burnet Institute, Heidelberg)
Claude BALNY (INSERM, Montpellier)
Xuetao CAO (The Second Military Medical University, Shanghai)
Chawnshang CHANG (University of Rochester, Rochester)
Kaixian CHEN (Shanghai Institute of Materia Medica, Shanghai)
Patrick C. CHOY (The University of Manitoba, Winnipeg)
Earl W. DAVIE (University of Washington, Seattle)
Linfang DU (Sichuan University, Chengdu)
Zuxun GONG (Institute of Biochemistry and Cell Biology, Shanghai)
Hua GU (Columbia University, New York)
Jianren GU (Shanghai Institute of Cancer Research, Shanghai)
Peixuan GUO (Purdue University, West Lafayette)
Yiping HAN (Case Western Reserve University, Cleveland)
Fuchu HE (Academy of Military Medical Sciences, Beijing)
Guangyuan HE (Huazhong University of Science and Technology, Wuhan)
Xianhui HE (Jinan University, Guangzhou)
Guofan HONG (Institute of Biochemistry and Cell Biology, Shanghai)
Zichun HUA(Nanjing University, Nanjing)
Weida HUANG (Fudan University, Shanghai)
James C. LEE (University of Texas Medical Branch, Galveston)
Yixue LI (Shanghai Institutes for Biological Sciences, Shanghai)
Zaiping LI(Institute of Biochemistry and Cell Biology, Shanghai)
Yi LIANG (Wuhan University, Wuhan)
Kan LIAO(Institute of Biochemistry and Cell Biology, Shanghai)
Dinggan LIU (Institute of Biochemistry and Cell Biology, Shanghai)
Xiaolong LIU (Institute of Biochemistry and Cell Biology, Shanghai)
Xinyuan LIU (Institute of Biochemistry and Cell Biology, Shanghai)
Hui LU (The University of Manchester, Manchester)
Yinkun LIU (Fudan University, Shanghai)
Zhenggang LIU (National Institutes of Health, Bethesda)
Zhengwu QI (Institute of Biochemistry and Cell Biology, Shanghai)
Boqin QIANG (Chinese Academy of Medical Sciences, Beijing)
Lianghu QU (Zhongshan University, Guangzhou)
Zihe RAO (Qinghua University, Beijing)
Yunyu SHI (University of Science and Technology of China, Hefei)
Hongbing SHU (Wuhan University, Wuhan)
Dieter SöLL (Yale University, New Haven)
Fangzhen SUN (Institute of Heredity and Development, Beijing)
Jordan J. N. TANG (Oklahoma Medical Research Foundation,Oklahoma City)
Teresa S. WANG (Stanford University, Stanford)
Zhixin WANG (Qinghua University, Beijing)
Zhizhen WANG (Institute of Biophyics, Beijing)
Michael S. WATERMAN (University of Southern California, Los Angeles)
Dianqing WU (Yale University School of Medicine, New Haven)
Jiarui WU (Institute of Biochemistry and Cell Biology, Shanghai)
Mian WU (University of Science and Technology of China, Hefei)
Zhengguo WU (Hong Kong University of Science and Technology, Hong Kong)
Jiahui XIA (Central South University, Changsha)
Xin XIANG (USUHS, Bethesda)
Zhengkai XU (Shanghai University, Shanghai)
Zhengping XU (Zhejiang University, Hangzhou)
Angang YANG (Fourth Military Medical University, Xi'an)
Shengli YANG (Shanghai Institutes for Biological Sciences, Shanghai)
Long YU (Fudan Unicverisity, Shanghai)
Yonglian ZHANG (Institute of Biochemistry and Cell Biology, Shanghai)
Guoping ZHAO (Institute of Plant Physiology and Ecology, Shanghai)
Boxiong ZHONG (Zhejiang University, Hangzhou)
Haimeng ZHOU (Qinghua University, Beijing)
Qunyong ZHOU (University of California, Irvine)
Lihuang ZHU (Institute of Heredity and Development, Beijing)
Xueliang ZHU (Institute of Biochemistry and Cell Biology, Shanghai)
Yuxian ZHU (Peking University, Beijing)
|
刊名字顺( Alphabetical List of Journals):
返回页首 